{"nct_id":"NCT04115839","title":"Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy","status":"TERMINATED","status_verified_date":"2022-02","start_date":"2019-11-13","start_date_type":"ACTUAL","primary_completion_date":"2021-01-04","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}